KWM
REGN icon

Kingsview Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Kingsview Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Sell
675
-64
-9% -$43.6K 0.01% 1057
2026
Q1 		$571K Sell
739
-72
-9% -$55.1K 0.01% 859
2025
Q4 		$626K Buy
811
+31
+4% +$21.1K 0.01% 777
2025
Q3 		$439K Sell
780
-128
-14% -$72.4K 0.01% 839
2025
Q2 		$477K Hold
908
– – 0.01% 783
2025
Q1 		$576K Sell
908
-94
-9% -$64.7K 0.01% 683
2024
Q4 		$714K Buy
1,002
+142
+17% +$119K 0.01% 641
2024
Q3 		$904K Buy
860
+22
+3% +$24.5K 0.02% 560
2024
Q2 		$881K Buy
838
+34
+4% +$33K 0.02% 545
2024
Q1 		$774K Hold
804
– – 0.02% 568
2023
Q4 		$706K Buy
804
+10
+1% +$8.23K 0.02% 559
2023
Q3 		$653K Buy
794
+108
+16% +$84.9K 0.02% 550
2023
Q2 		$493K Sell
686
-1
-0.1% -$771 0.02% 592
2023
Q1 		$564K Sell
687
-21
-3% -$15.8K 0.02% 543
2022
Q4 		$511K Sell
708
-114
-14% -$84.1K 0.02% 504
2022
Q3 		$566K Buy
822
+91
+12% +$57.3K 0.03% 471
2022
Q2 		$432K Buy
731
+22
+3% +$14.3K 0.02% 569
2022
Q1 		$495K Buy
709
+18
+3% +$11.4K 0.02% 574
2021
Q4 		$436K Sell
691
-125
-15% -$76.9K 0.02% 619
2021
Q3 		$494K Buy
816
+115
+16% +$71.4K 0.02% 547
2021
Q2 		$403K Buy
701
+50
+8% +$25.3K 0.02% 617
2021
Q1 		$309K Buy
651
+23
+4% +$11.2K 0.02% 632
2020
Q4 		$303K Sell
628
-367
-37% -$198K 0.02% 551
2020
Q3 		$557K Sell
995
-25
-2% -$15.2K 0.05% 343
2020
Q2 		$636K Sell
1,020
-62
-6% -$35.2K 0.06% 283
2020
Q1 		$528K Buy
+1,082
New +$446K 0.07% 260

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kingsview Wealth Management's REGN Position: Q2 2026 in Review

Kingsview Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 8.7% in Q2 2026, selling an estimated $43.6K and leaving 675 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #1057.

Kingsview Wealth Management first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $904K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Kingsview Wealth Management held 675 shares of Regeneron Pharmaceuticals worth $421K as of Q2 2026.
  • Kingsview Wealth Management sold 64 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $43.6K.
  • Regeneron Pharmaceuticals made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #1057 holding.
  • Kingsview Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Kingsview Wealth Management's Regeneron Pharmaceuticals position peaked at $904K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.